Singapore, Singapore

Xiao Jing Yang


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xiao Jing Yang

Introduction

Xiao Jing Yang is a notable inventor based in Singapore, SG. He has made significant contributions to the field of cancer therapy and stem cell research. With a total of 2 patents, his work focuses on innovative methods that have the potential to impact medical treatments.

Latest Patents

Xiao Jing Yang's latest patents include groundbreaking methods for cancer therapy and stem cell modulation. The first patent describes a method of modulating the pluripotency and self-renewing characteristics of stem/progenitor cells. This method involves administering a compound of a specific general formula, where A can be either carbon or nitrogen, and R groups are selected from various hydrocarbyl groups. The second patent outlines a method for inducing apoptosis in tumor cells while also modulating stem cell characteristics. This invention also utilizes a compound defined by a similar general formula, emphasizing the importance of specific chemical structures in achieving desired therapeutic effects.

Career Highlights

Xiao Jing Yang is affiliated with the Agency for Science, Technology and Research, where he conducts his research and development. His work is characterized by a strong focus on innovative solutions to complex medical challenges.

Collaborations

Xiao Jing Yang collaborates with esteemed colleagues, including Qiang Yu and Jing Kai Tan, who contribute to his research endeavors.

Conclusion

Xiao Jing Yang's contributions to cancer therapy and stem cell research highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing effective treatments that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…